Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Emma Foreman"'
Publikováno v:
BMC Nursing, Vol 21, Iss 1, Pp 1-9 (2022)
Abstract Background Due to an increase in patient numbers, more cancer patients are being reviewed by non-medical healthcare professionals (HCPs), and it is essential that they can empathise with patients and care for them holistically. ‘A Life in
Externí odkaz:
https://doaj.org/article/47dd34372ee94aa19f4360e0c9c9f44e
Histamine‐2 (H 2 ) antagonists can be safely removed from standard paclitaxel premedication regimens
Publikováno v:
British Journal of Clinical Pharmacology. 88:4191-4198
Autor:
Hasan Kobat, Islam Elkonaissi, Emma Foreman, Mary O’Brien, Mehmet Tevfik Dorak, Shereen Nabhani-Gebara
Peer reviewed: True
BACKGROUND.: Oncology clinical trials demonstrate the risk of cardiotoxicity but are not sufficient to reveal the true risk. In this article, we compared the incidence of cardiotoxicity of crizotinib and osimertinib from a re
BACKGROUND.: Oncology clinical trials demonstrate the risk of cardiotoxicity but are not sufficient to reveal the true risk. In this article, we compared the incidence of cardiotoxicity of crizotinib and osimertinib from a re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::263693ed11210593bb816119d6515aec
https://www.repository.cam.ac.uk/handle/1810/348154
https://www.repository.cam.ac.uk/handle/1810/348154
Autor:
Emma Foreman
Publikováno v:
Veterinary Nursing Journal. 36:182-186
Rabbits are complex animals with many requirements for them to thrive in the domestic environment. As prey animals, rabbits instinctively mask the signs of illness to avoid appearing vulnerable to ...
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522311643
Introduction The tyrosine-kinase inhibitor osimertinib is an oral anti-cancer agent that is used for the treatment of patients with metastatic non-small cell lung cancer harbouring sensitising EGFR mutations. Patients receiving osimertinib are at hig
Autor:
Emma Foreman
Publikováno v:
Veterinary Nursing Journal. 35:372-376
This is the second part of a two-part article outlining the pathophysiology of sepsis and the implementation of a critical care framework to assist veterinary nurses to understand the disease and h...
Publikováno v:
British journal of clinical pharmacology. 88(9)
The aim of this study is to investigate the rates of hypersensitivity reactions (HSRs) in patients receiving paclitaxel chemotherapy, with and without a histamine-2 (HThis prospective, multi-centre, cohort study compared patients receiving paclitaxel
Autor:
Emma Foreman
Publikováno v:
Veterinary Nursing Journal. 35:242-245
This two-part article aims to provide the knowledge and understanding for nurses to gain the confidence necessary to provide care for patients with sepsis in a critical care environment. It include...
Autor:
Emma Foreman
Publikováno v:
Current Opinion in Oncology. 32:282-288
Purpose of review This review covers recent publications relating to the use of biosimilar medicines in the supportive care of cancer patients, and broader publications focussed on the benefits and challenges of implementing biosimilars into clinical
Autor:
Barbara Yim, Mário L de Lemos, Maggie Patterson, Alexandre Chan, Shaun O'Connor, Mayde Seadi Torriani, Hisanaga Nomura, Milagros Cubilla, Morgan B. Frazer, Jim Siderov, Emma Foreman, Rodrigo Spineli Macedo, Joseph S. Bubalo, Harbans Dhillon, Nirachorn Kuchonthara, Winnie Mwangi, Annemeri Livinalli, Himanshu Patel, Jatinder Harchowal
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:3-10
With the development of innovative cancer treatments over recent decades, the cost of cancer care has risen exponentially, limiting patient access to patented originator biotherapeutics in many countries. The introduction of biosimilars to the market